Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease

Physiological Research

Volumn 61, Issue 5, 2012, Pages 469-480

  Brusik M ^a   Ukropec, J ^b   Joppa, P ^a   Ukropcova B ^b   Skyba, P ^a   Balaz M ^b   Pobeha, P ^a   Kurdiova T ^b   Klimes I ^b   Tkac I ^a   Gasperikova D ^b   Tkacova R ^a  

^a Med Faculty of Safarik University   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Adiponectin; Adipose tissue; Chronic obstructive pulmonary disease; Leptin; Resting energy expenditure

Indexed keywords

EID: 84873829011     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. AGUSTÍ A, MORLÁ M, SAULEDA J, SAUS C, BUSQUETS X: NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59: 483-487, 2004.
2. BING C, RUSSELL S, BECKET E, POPE M, TISDALE MJ, TRAYHURN P, JENKINS JR: Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer 95: 1028-1037, 2006.
3. BREYER MK, RUTTEN EP, VERNOOY JH, SPRUIT MA, DENTENER MA, VAN DER KALLEN C, VANGREEVENBROEK MM, WOUTERS EF. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 105: 1046-1053, 2011.
4. CHAN KH, YEUNG SC, YAO TJ, IP MS, CHEUNG AH, CHAN-YEUNG MM, MAK JC; COPD STUDY GROUP OF THE HONG KONG THORACIC SOCIETY: Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 14: 1193-1200, 2010.
5. COHEN RI, MARZOUK K, BERKOSKI P, O'DONNELL CP, POLOTSKY VY, SCHARF SM: Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema. Chest 124: 1365-1372, 2003.
6. CREUTZBERG EC, SCHOLS AM, BOTHMER-QUAEDVLIEG FC, WOUTERS EF: Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 52: 396-401, 1998.
7. DEEMER SE, KING GA, DORGO S, VELLA CA, TOMAKA JW, THOMPSON DL: Relationship of leptin, resting metabolic rate, and body composition in premenopausal hispanic and non-hispanic white women. Endocrine Res 35: 95-105, 2010.
8. DELLWEG D, HAIDL P, SIEMON K, APPELHANS P, KOEHLER D: Impact of breathing pattern on work of breathing in healthy subjects and patients with COPD. Respir Physiol Neurobiol 161: 197-200, 2008.
9. DONAHOE M, ROGERS RM, WILSON DO, PENNOCK BE: Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 140: 385-391, 1989.
10. ENGELEN MP, SCHOLS AM, LAMERS RJ, WOUTERS EF: Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 18: 275-280, 1999.
11. FATOUROS IG, CHATZINIKOLAOU A, TOURNIS S, NIKOLAIDIS MG, JAMURTAS AZ, DOUROUDOS II, PAPASSOTIRIOU I, THOMAKOS PM, TAXILDARIS K, MASTORAKOS G, MITRAKOU A: Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diab Care 32: 2161-2167, 2009.
12. FERRARO R, RAVUSSIN E: Fat mass in predicting resting metabolic rate. Am J Clin Nutr 56: 460-461, 1992.
13. FOULADIUN M, KÖRNER U, BOSAEUS I, DANERYD P, HYLTANDER A, LUNDHOLM KG: Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103: 2189-2198, 2005.
14. FRANSSEN FM, O'DONNELL DE, GOOSSENS GH, BLAAK EE, SCHOLS AM: Obesity and the lung: 5. Obesity and COPD. Thorax 63: 1110-1117, 2008.
15. FREDRIX EWHM, SOETERS PB, WOUTERS EFM, DEERENBERG IM, VON MEYENFELDT MF, SARIS WHM: Effect of different tumor types on resting energy expenditure. Cancer Res 51: 6138-6141, 1991.
16. HAMANN A, MATTHAEI S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diab 104: 293-300, 1996.
17. JØRGENSEN JO, VAHL N, DALL R, CHRISTIANSEN JS: Resting metabolic rate in healthy adults: relation to growth hormone status and leptin levels. Metabolism 47: 1134-1139, 1998.
18. KLEIN D: Quantification using real-time PCR technology: applications and limitations. Trends Mol Med 8: 257-260, 2002.
19. LANDBO C, PRESCOTT E, LANGE P, VESTBO J, ALMDAL TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1856-1861, 1999.
20. LIU X, JI Y, CHEN J, LI S, LUO F: Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 25: 373-378, 2009.
21. MAGNI P, LIUZZI A, RUSCICA M, DOZIO E, FERRARIO S, BUSSI I, MINOCCI A, CASTAGNA A, MOTTA M, SAVIA G: Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol (Oxf) 62: 189-196, 2005.
22. MILLER MR, HANKINSON J, BRUSASCO V, BURGOS F, CASABURI R, COATES A, CRAPO R, ENRIGHT P, VAN DER GRINTEN CP, GUSTAFSSON P, JENSEN R, JOHNSON DC, MACINTYRE N, MCKAY R, NAVAJAS D, PEDERSEN OF, PELLEGRINO R, VIEGI G, WANGER J; ATS/ERS TASK FORCE: Standardisation of spirometry. Eur Respir J 26: 319-338, 2005.
23. MOTOSHIMA H, WU X, SINHA MK, HARDY VE, ROSATO EL, BARBOT DJ, ROSATO FE, GOLDSTEIN BJ: Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87: 5662-5667, 2002.
24. MURPHY RA, WILKE MS, PERRINE M, PAWLOWICZ M, MOURTZAKIS M, LIEFFERS JR, MANESHGAR M, BRUERA E, CLANDININ MT, BARACOS VE, MAZURAK VC: Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr 29: 482-487, 2010.
25. NEUHÄUSER-BERTHOLD M, HERBERT BM, LÜHRMANN PM, SÜLTEMEIER AA, BLUM WF, FREY J, HEBEBRAND J: Resting metabolic rate, body composition, and serum leptin concentrations in a free-living elderly population. Eur J Endocrinol 142: 486-492, 2000.
26. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) WORKSHOP: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2010 Update. Available from: http://www.goldcopd.com
27. NISKANEN L, HAFFNER S, KARHUNEN LJ, TURPEINEN AK, MIETTINEN H, UUSITUPA MI: Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects. Int J Obes Relat Metab Disord 21: 309-313, 1997.
28. PANNACCIULLI N, VETTOR R, MILAN G, GRANZOTTO M, CATUCCI A, FEDERSPIL G, DE GIACOMO P, GIORGINO R, DE PERGOLA G: Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88: 1748-1752, 2003.
29. PELLEYMOUNTER MA, CULLEN MJ, BAKER MB, HECHT R, WINTERS D, BOONE T, COLLINS F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995..
30. RAGUSO CA, LUTHY C: Nutritional status in chronic obstructive pulmonary disease: role of hypoxia. Nutrition 27: 138-143, 2011
31. SCHOLS AM, FREDRIX EW, SOETERS PB, WESTERTERP KR, WOUTERS EF: Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 54: 983-987, 1991a.
32. SCHOLS AM, SOETERS PB, MOSTERT R, SARIS WH, WOUTERS EF: Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis 143: 1248-1252, 1991b.
33. SCHOLS AM, CREUTZBERG EC, BUURMAN WA, CAMPFIELD LA, SARIS WH, WOUTERS EF: Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1220-1226, 1999.
34. SERGI G, COIN A, MARIN S, VIANELLO A, MANZAN A, PERUZZA S, INELMEN EM, BUSETTO L, MULONE S, ENZI G: Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Respir Med 100: 1918-1924, 2006.
35. SHIN KC, CHUNG JH, LEE KH: Effects of TNF-alpha and leptin on weight loss in patients with stable chronic obstructive pulmonary disease. Korean J Intern Med 22: 249-255, 2007.
36. SMIECHOWSKA J, UTECH A, TAFFET G, HAYES T, MARCELLI M, GARCIA JM: Adipokines in patients with cancer anorexia and cachexia. J Investig Med 58: 554-559, 2010.
37. TOMODA K, YOSHIKAWA M, ITOH T, TAMAKI S, FUKUOKA A, KOMEDA K, KIMURA H: Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 132: 135-140, 2007.
38. TRAYHURN P, BING C: Appetite and energy balance signals from adipocytes. Philos Trans R Soc Lond B Biol Sci 361: 1237-1249, 2006.
39. USUI C, TAKAHASHI E, GANDO Y, SANADA K, OKA J, MIYACHI M, TABATA I, HIGUCHI M: Relationship between blood adipocytokines and resting energy expenditure in young and elderly women. J Nutr Sci Vitaminol (Tokyo) 53: 529-535, 2007.
40. VESTBO J, PRESCOTT E, ALMDAL T, DAHL M, NORDESTGAARD BG, ANDERSEN T, SØRENSEN TI, LANGE P: Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173: 79-83, 2006.
41. WAGNER PD: Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31: 492-501, 2008.
42. WEIR JB: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1-9, 1949.
43. WOLF I, SADETZKI S, KANETY H, KUNDEL Y, PARIENTE C, EPSTEIN N, OBERMAN B, CATANE R, KAUFMAN B, SHIMON I: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106: 966-973, 2006.
44. YANG YM, SUN TY, LIU XM: The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J (Engl) 119: 628-633, 2006.